{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:39:44Z","timestamp":1788813584700,"version":"build-2803163510"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/12\/IYBA\/2020\/07"],"award-info":[{"award-number":["BT\/12\/IYBA\/2020\/07"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07153-3","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T14:36:00Z","timestamp":1762958160000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Deciphering context-specific Axitinib escape pathways via multi-omics and explainable machine learning"],"prefix":"10.1186","volume":"23","author":[{"given":"Samriddhi","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khyati","family":"Patni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simarpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4226-3063","authenticated-orcid":false,"given":"Jaspreet Kaur","family":"Dhanjal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"7153_CR1","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/J.CELL.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374. https:\/\/doi.org\/10.1016\/J.CELL.2011.02.013.","journal-title":"Cell"},{"key":"7153_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/J.DRUP.2019.100643","author":"T Alexa-Stratulat","year":"2019","unstructured":"Alexa-Stratulat T, Pe\u0161i\u0107 M, Ga\u0161parovi\u0107 A\u010c, Trougakos IP, Riganti C. What sustains the multidrug resistance phenotype beyond ABC efflux transporters? Looking beyond the tip of the iceberg. Drug Resist Updat. 2019;46:100643. https:\/\/doi.org\/10.1016\/J.DRUP.2019.100643","journal-title":"Drug Resist Updat"},{"key":"7153_CR3","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.1038\/S41388-018-0185-4","volume":"37","author":"L Duplaquet","year":"2018","unstructured":"Duplaquet L, Kherrouche Z, Baldacci S, Jamme P, Cortot AB, Copin MC, et al. The multiple paths towards MET receptor addiction in cancer. Oncogene. 2018;37:3200\u201315. https:\/\/doi.org\/10.1038\/S41388-018-0185-4.","journal-title":"Oncogene"},{"key":"7153_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/J.DRUP.2019.07.004","volume":"45","author":"E Kon","year":"2019","unstructured":"Kon E, Benhar I. Immune checkpoint inhibitor combinations: current efforts and important aspects for success. Drug Resist Updat. 2019;45:13\u201329. https:\/\/doi.org\/10.1016\/J.DRUP.2019.07.004.","journal-title":"Drug Resist Updat"},{"key":"7153_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS19113491","author":"T Yamaoka","year":"2018","unstructured":"Yamaoka T, Kusumoto S, Ando K, Ohba M, Ohmori T. Receptor tyrosine kinase-targeted cancer therapy. Int J Mol Sci. 2018;19(11):3491. https:\/\/doi.org\/10.3390\/IJMS19113491","journal-title":"Int J Mol Sci"},{"key":"7153_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/J.BIOPHA.2019.108800","volume":"114","author":"X Ji","year":"2019","unstructured":"Ji X, Lu Y, Tian H, Meng X, Wei M, Cho WC. Chemoresistance mechanisms of breast cancer and their countermeasures. Biomed Pharmacother. 2019;114:108800. https:\/\/doi.org\/10.1016\/J.BIOPHA.2019.108800.","journal-title":"Biomed Pharmacother"},{"key":"7153_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/CANCERS11081166","author":"XH Khoo","year":"2019","unstructured":"Khoo XH, Paterson IC, Goh BH, Lee WL. Cisplatin-resistance in oral squamous cell carcinoma: regulation by tumor cell-derived extracellular vesicles. Cancers (Basel). 2019;11(8):1166 https:\/\/doi.org\/10.3390\/CANCERS11081166","journal-title":"Cancers (Basel)"},{"key":"7153_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/J.DRUP.2014.12.001","volume":"18","author":"D Niewerth","year":"2015","unstructured":"Niewerth D, Jansen G, Assaraf YG, Zweegman S, Kaspers GJL, Cloos J. Molecular basis of resistance to proteasome inhibitors in hematological malignancies. Drug Resist Updat. 2015;18:18\u201335. https:\/\/doi.org\/10.1016\/J.DRUP.2014.12.001.","journal-title":"Drug Resist Updat"},{"key":"7153_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/J.DRUP.2017.05.002","volume":"31","author":"M Bar-Zeev","year":"2017","unstructured":"Bar-Zeev M, Livney YD, Assaraf YG. Targeted nanomedicine for cancer therapeutics: towards precision medicine overcoming drug resistance. Drug Resist Updat. 2017;31:15\u201330. https:\/\/doi.org\/10.1016\/J.DRUP.2017.05.002.","journal-title":"Drug Resist Updat"},{"key":"7153_CR10","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1016\/J.ADDR.2013.08.006","volume":"65","author":"YD Livney","year":"2013","unstructured":"Livney YD, Assaraf YG. Rationally designed nanovehicles to overcome cancer chemoresistance. Adv Drug Deliv Rev. 2013;65:1716\u201330. https:\/\/doi.org\/10.1016\/J.ADDR.2013.08.006.","journal-title":"Adv Drug Deliv Rev"},{"key":"7153_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/S13073-017-0431-3","author":"LG Ahronian","year":"2017","unstructured":"Ahronian LG, Corcoran RB. Strategies for monitoring and combating resistance to combination kinase inhibitors for cancer therapy. Genome Med. 2017;9:37. https:\/\/doi.org\/10.1186\/S13073-017-0431-3","journal-title":"Genome Med"},{"key":"7153_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/J.DRUP.2016.07.001","volume":"28","author":"RH Wijdeven","year":"2016","unstructured":"Wijdeven RH, Pang B, Assaraf YG, Neefjes J. Old drugs, novel ways out: drug resistance toward cytotoxic chemotherapeutics. Drug Resist Updat. 2016;28:65\u201381. https:\/\/doi.org\/10.1016\/J.DRUP.2016.07.001.","journal-title":"Drug Resist Updat"},{"key":"7153_CR13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/J.DRUP.2016.06.004","volume":"28","author":"S Raz","year":"2016","unstructured":"Raz S, Stark M, Assaraf YG. Folylpoly-\u03b3-glutamate synthetase: a key determinant of folate homeostasis and antifolate resistance in cancer. Drug Resist Updat. 2016;28:43\u201364. https:\/\/doi.org\/10.1016\/J.DRUP.2016.06.004.","journal-title":"Drug Resist Updat"},{"key":"7153_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/J.DRUP.2015.11.004","volume":"24","author":"B Zhitomirsky","year":"2016","unstructured":"Zhitomirsky B, Assaraf YG. Lysosomes as mediators of drug resistance in cancer. Drug Resist Updat. 2016;24:23\u201333. https:\/\/doi.org\/10.1016\/J.DRUP.2015.11.004.","journal-title":"Drug Resist Updat"},{"key":"7153_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12935-015-0221-1\/FIGURES\/3","volume":"15","author":"KO Alfarouk","year":"2015","unstructured":"Alfarouk KO, Stock CM, Taylor S, Walsh M, Muddathir AK, Verduzco D, et al. Resistance to cancer chemotherapy: Failure in drug response from ADME to P-gp. Cancer Cell Int. 2015;15:1\u201313. https:\/\/doi.org\/10.1186\/S12935-015-0221-1\/FIGURES\/3.","journal-title":"Cancer Cell Int"},{"key":"7153_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/J.DRUP.2019.100645","volume":"46","author":"YG Assaraf","year":"2019","unstructured":"Assaraf YG, Brozovic A, Gon\u00e7alves AC, Jurkovicova D, Lin\u0113 A, Machuqueiro M, et al. The multi-factorial nature of clinical multidrug resistance in cancer. Drug Resist Updat. 2019;46:100645. https:\/\/doi.org\/10.1016\/J.DRUP.2019.100645.","journal-title":"Drug Resist Updat"},{"key":"7153_CR17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/NRCLINONC.2017.166","volume":"15","author":"I Dagogo-Jack","year":"2018","unstructured":"Dagogo-Jack I, Shaw AT. Tumour heterogeneity and resistance to cancer therapies. Nat Rev Clin Oncol. 2018;15:81\u201394. https:\/\/doi.org\/10.1038\/NRCLINONC.2017.166.","journal-title":"Nat Rev Clin Oncol"},{"key":"7153_CR18","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/J.MOLONC.2014.06.005","volume":"8","author":"RA Burrell","year":"2014","unstructured":"Burrell RA, Swanton C. Tumour heterogeneity and the evolution of polyclonal drug resistance. Mol Oncol. 2014;8:1095\u2013111. https:\/\/doi.org\/10.1016\/J.MOLONC.2014.06.005.","journal-title":"Mol Oncol"},{"key":"7153_CR19","doi-asserted-by":"publisher","first-page":"6424","DOI":"10.1158\/0008-5472.CAN-12-4573","volume":"73","author":"S Garcia-Recio","year":"2013","unstructured":"Garcia-Recio S, Fuster G, Fernandez-Nogueira P, Pastor-Arroyo EM, Park SY, Mayordomo C, et al. Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer. Cancer Res. 2013;73:6424\u201334. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-4573.","journal-title":"Cancer Res"},{"key":"7153_CR20","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1126\/SCIENCE.1235122","volume":"339","author":"B Vogelstein","year":"2013","unstructured":"Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA, Kinzler KW. Cancer genome landscapes. Science. 2013;339:1546\u201358. https:\/\/doi.org\/10.1126\/SCIENCE.1235122.","journal-title":"Science"},{"key":"7153_CR21","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/NM.4040","volume":"22","author":"AN Hata","year":"2016","unstructured":"Hata AN, Niederst MJ, Archibald HL, Gomez-Caraballo M, Siddiqui FM, Mulvey HE, et al. Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition. Nat Med. 2016;22:262\u20139. https:\/\/doi.org\/10.1038\/NM.4040.","journal-title":"Nat Med"},{"key":"7153_CR22","doi-asserted-by":"publisher","DOI":"10.1101\/CSHPERSPECT.A008912","author":"J Schlessinger","year":"2014","unstructured":"Schlessinger J. Receptor tyrosine kinases: legacy of the first two decades. Cold Spring Harb Perspect Biol. 2014;6(3):a008912. https:\/\/doi.org\/10.1101\/CSHPERSPECT.A008912","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"7153_CR23","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2165\/11591240-000000000-00000","volume":"11","author":"B Escudier","year":"2011","unstructured":"Escudier B, Gore M. Axitinib for the management of metastatic renal cell carcinoma. Drugs R D. 2011;11:113\u201326. https:\/\/doi.org\/10.2165\/11591240-000000000-00000.","journal-title":"Drugs R D"},{"key":"7153_CR24","doi-asserted-by":"publisher","first-page":"3767","DOI":"10.1182\/BLOOD-2002-01-0109","volume":"100","author":"M Mayerhofer","year":"2002","unstructured":"Mayerhofer M, Valent P, Sperr WR, Griffin JD, Sillaber C. BCR\/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1\u03b1, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin. Blood. 2002;100:3767\u201375. https:\/\/doi.org\/10.1182\/BLOOD-2002-01-0109.","journal-title":"Blood"},{"key":"7153_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/NAR\/GKS1111","author":"W Yang","year":"2013","unstructured":"Yang W, Soares J, Greninger P, Edelman EJ, Lightfoot H, Forbes S, et al. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 2013;41(Database issue):D955-61. https:\/\/doi.org\/10.1093\/NAR\/GKS1111","journal-title":"Nucleic Acids Res"},{"key":"7153_CR26","unstructured":"Targeted Therapy Drug List by Cancer Type - NCI n.d. https:\/\/www.cancer.gov\/about-cancer\/treatment\/types\/targeted-therapies\/approved-drug-list. Accessed March 27, 2025."},{"key":"7153_CR27","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/nar\/gky872","volume":"47","author":"D Van Der Meer","year":"2018","unstructured":"Van Der Meer D, Barthorpe S, Yang W, Lightfoot H, Hall C, Gilbert J, et al. Cell Model Passports-a hub for clinical, genetic and functional datasets of preclinical cancer models. Nucleic Acids Res. 2018;47:923\u20139. https:\/\/doi.org\/10.1093\/nar\/gky872.","journal-title":"Nucleic Acids Res"},{"key":"7153_CR28","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3233\/FI-2010-288","volume":"101","author":"MB Kursa","year":"2010","unstructured":"Kursa MB, Jankowski A, Rudnicki WR. Boruta \u2013 a system for feature selection. Fundam Inform. 2010;101:271\u201385. https:\/\/doi.org\/10.3233\/FI-2010-288.","journal-title":"Fundam Inform"},{"issue":"3","key":"7153_CR29","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3390\/MAKE3030027","volume":"3","author":"MR Zafar","year":"2021","unstructured":"Zafar MR, Khan N. Deterministic local interpretable model-agnostic explanations for stable explainability. Mach Learn Knowl Extr. 2021;3(3):525\u201341. https:\/\/doi.org\/10.3390\/MAKE3030027.","journal-title":"Mach Learn Knowl Extr"},{"key":"7153_CR30","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/PRO.3711","volume":"29","author":"M Kanehisa","year":"2020","unstructured":"Kanehisa M, Sato Y. KEGG mapper for inferring cellular functions from protein sequences. Protein Sci. 2020;29:28\u201335. https:\/\/doi.org\/10.1002\/PRO.3711.","journal-title":"Protein Sci"},{"key":"7153_CR31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/NAR\/27.1.29","volume":"27","author":"H Ogata","year":"1999","unstructured":"Ogata H, Goto S, Sato K, Fujibuchi W, Bono H, Kanehisa M. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 1999;27:29\u201334. https:\/\/doi.org\/10.1093\/NAR\/27.1.29.","journal-title":"Nucleic Acids Res"},{"key":"7153_CR32","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/BIB\/BBX124","volume":"20","author":"F Degenhardt","year":"2019","unstructured":"Degenhardt F, Seifert S, Szymczak S. Evaluation of variable selection methods for random forests and omics data sets. Brief Bioinform. 2019;20:492\u2013503. https:\/\/doi.org\/10.1093\/BIB\/BBX124.","journal-title":"Brief Bioinform"},{"issue":"3","key":"7153_CR33","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/J.CARDIORES.2004.12.002","volume":"65","author":"T Tammela","year":"2005","unstructured":"Tammela T, Enholm B, Alitalo K, Paavonen K. The biology of vascular endothelial growth factors. Cardiovasc Res. 2005;65(3):550\u201363. https:\/\/doi.org\/10.1016\/J.CARDIORES.2004.12.002.","journal-title":"Cardiovasc Res"},{"key":"7153_CR34","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1210\/ER.2003-0027","volume":"25","author":"N Ferrara","year":"2004","unstructured":"Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev. 2004;25:581\u2013611. https:\/\/doi.org\/10.1210\/ER.2003-0027.","journal-title":"Endocr Rev"},{"key":"7153_CR35","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/S00018-005-5426-3","volume":"63","author":"S C\u00e9be-Suarez","year":"2006","unstructured":"C\u00e9be-Suarez S, Zehnder-Fj\u00e4llman A, Ballmer-Hofer K. The role of VEGF receptors in angiogenesis; complex partnerships. Cell Mol Life Sci. 2006;63:601\u201315. https:\/\/doi.org\/10.1007\/S00018-005-5426-3.","journal-title":"Cell Mol Life Sci"},{"key":"7153_CR36","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1023\/A:1009033017809\/METRICS","volume":"3","author":"C Hornig","year":"1999","unstructured":"Hornig C, Weich HA. Soluble VEGF receptors: Recombinant and naturally occurring forms involved in the regulation of angiogenesis. Angiogenesis. 1999;3:33\u20139. https:\/\/doi.org\/10.1023\/A:1009033017809\/METRICS.","journal-title":"Angiogenesis"},{"key":"7153_CR37","doi-asserted-by":"publisher","first-page":"8795","DOI":"10.1073\/PNAS.95.15.8795\/ASSET\/DFB97E12-F61E-4E61-81BB-C8F66F7789E2\/ASSETS\/GRAPHIC\/PQ1583908005.JPEG","volume":"95","author":"CK Goldman","year":"1998","unstructured":"Goldman CK, Kendall RL, Cabrera G, Soroceanu L, Heike Y, Gillespie GY, et al. Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate. Proc Natl Acad Sci U S A. 1998;95:8795\u2013800. https:\/\/doi.org\/10.1073\/PNAS.95.15.8795\/ASSET\/DFB97E12-F61E-4E61-81BB-C8F66F7789E2\/ASSETS\/GRAPHIC\/PQ1583908005.JPEG.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7153_CR38","doi-asserted-by":"publisher","first-page":"10705","DOI":"10.1073\/PNAS.90.22.10705","volume":"90","author":"RL Kendall","year":"1993","unstructured":"Kendall RL, Thomas KA. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci U S A. 1993;90:10705\u20139. https:\/\/doi.org\/10.1073\/PNAS.90.22.10705.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7153_CR39","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1152\/PHYSREV.00005.2002","volume":"82","author":"L Jussila","year":"2002","unstructured":"Jussila L, Alitalo K. Vascular growth factors and lymphangiogenesis. Physiol Rev. 2002;82:673\u2013700. https:\/\/doi.org\/10.1152\/PHYSREV.00005.2002.","journal-title":"Physiol Rev"},{"key":"7153_CR40","doi-asserted-by":"publisher","first-page":"18281","DOI":"10.1073\/PNAS.1207759109","volume":"109","author":"M McTigue","year":"2012","unstructured":"McTigue M, Murray BW, Chen JH, Deng YL, Solowiej J, Kania RS. Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors. Proc Natl Acad Sci U S A. 2012;109:18281\u20139. https:\/\/doi.org\/10.1073\/PNAS.1207759109.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7153_CR41","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1242\/DMM.004077","volume":"4","author":"TR Cox","year":"2011","unstructured":"Cox TR, Erler JT. Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer. DMM Dis Model Mech. 2011;4:165\u201378. https:\/\/doi.org\/10.1242\/DMM.004077.","journal-title":"DMM Dis Model Mech"},{"key":"7153_CR42","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1242\/JCS.067009","volume":"124","author":"PP Provenzano","year":"2011","unstructured":"Provenzano PP, Keely PJ. Mechanical signaling through the cytoskeleton regulates cell proliferation by coordinated focal adhesion and Rho GTPase signaling. J Cell Sci. 2011;124:1195\u2013205. https:\/\/doi.org\/10.1242\/JCS.067009.","journal-title":"J Cell Sci"},{"key":"7153_CR43","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ccr.2005.08.010","volume":"8","author":"MJ Paszek","year":"2005","unstructured":"Paszek MJ, Zahir N, Johnson KR, Lakins JN, Rozenberg GI, Gefen A, et al. Tensional homeostasis and the malignant phenotype. Cancer Cell. 2005;8:241\u201354. https:\/\/doi.org\/10.1016\/j.ccr.2005.08.010.","journal-title":"Cancer Cell"},{"key":"7153_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/J.BIOMATERIALS.2019.119371","volume":"219","author":"S Pedron","year":"2019","unstructured":"Pedron S, Wolter GL, Chen JWE, Laken SE, Sarkaria JN, Harley BAC. Hyaluronic acid-functionalized gelatin hydrogels reveal extracellular matrix signals temper the efficacy of erlotinib against patient-derived glioblastoma specimens. Biomaterials. 2019;219:119371. https:\/\/doi.org\/10.1016\/J.BIOMATERIALS.2019.119371.","journal-title":"Biomaterials"},{"key":"7153_CR45","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1111\/CAS.13624","volume":"109","author":"S Yamazaki","year":"2018","unstructured":"Yamazaki S, Higuchi Y, Ishibashi M, Hashimoto H, Yasunaga M, Matsumura Y, et al. Collagen type I induces EGFR-TKI resistance in EGFR-mutated cancer cells by mTOR activation through Akt-independent pathway. Cancer Sci. 2018;109:2063\u201373. https:\/\/doi.org\/10.1111\/CAS.13624.","journal-title":"Cancer Sci"},{"key":"7153_CR46","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.ccell.2020.05.005","volume":"37","author":"Y Shen","year":"2020","unstructured":"Shen Y, Wang X, Lu J, Salfenmoser M, Wirsik NM, Schleussner N, et al. Reduction of liver metastasis stiffness improves response to Bevacizumab in metastatic colorectal cancer. Cancer Cell. 2020;37:800-817.e7. https:\/\/doi.org\/10.1016\/j.ccell.2020.05.005.","journal-title":"Cancer Cell"},{"key":"7153_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/CANCERS11050692","author":"EC Da Silva","year":"2019","unstructured":"Da Silva EC, Dontenwill M, Choulier L, Lehmann M. Role of integrins in resistance to therapies targeting growth factor receptors in cancer. Cancers (Basel). 2019;11(5):692. https:\/\/doi.org\/10.3390\/CANCERS11050692","journal-title":"Cancers (Basel)"},{"key":"7153_CR48","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1007\/S11864-022-01006-7","volume":"23","author":"Y Chen","year":"2022","unstructured":"Chen Y, Zhong J, Sun W, Yan W, Wang C, Liu W, et al. BRAF inhibitor resistance in melanoma: mechanisms and alternative therapeutic strategies. Curr Treat Options Oncol. 2022;23:1503\u201321. https:\/\/doi.org\/10.1007\/S11864-022-01006-7.","journal-title":"Curr Treat Options Oncol"},{"key":"7153_CR49","doi-asserted-by":"publisher","first-page":"3972","DOI":"10.7150\/THNO.18990","volume":"7","author":"YE Du","year":"2017","unstructured":"Du YE, Tu G, Yang G, Li G, Yang D, Lang L, et al. Mir-205\/YAP1 in activated fibroblasts of breast tumor promotes VEGF-independent angiogenesis through STAT3 signaling. Theranostics. 2017;7:3972. https:\/\/doi.org\/10.7150\/THNO.18990.","journal-title":"Theranostics"},{"key":"7153_CR50","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/1440-1681.12581","volume":"43","author":"ST Pan","year":"2016","unstructured":"Pan ST, Li ZL, He ZX, Qiu JX, Zhou SF. Molecular mechanisms for tumour resistance to chemotherapy. Clin Exp Pharmacol Physiol. 2016;43:723\u201337. https:\/\/doi.org\/10.1111\/1440-1681.12581.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"7153_CR51","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1158\/1541-7786.MCR-18-1243","volume":"17","author":"EH Stover","year":"2019","unstructured":"Stover EH, Baco MB, Cohen O, Li YY, Christie EL, Bagul M, et al. Pooled genomic screens identify anti-apoptotic genes as targetable mediators of chemotherapy resistance in ovarian cancer. Mol Cancer Res. 2019;17:2281. https:\/\/doi.org\/10.1158\/1541-7786.MCR-18-1243.","journal-title":"Mol Cancer Res"},{"key":"7153_CR52","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/J.JMB.2006.12.027","volume":"366","author":"SX Li","year":"2007","unstructured":"Li SX, Tong YP, Xie XC, Wang QH, Zhou HN, Han Y, et al. Octameric structure of the human bifunctional enzyme PAICS in purine biosynthesis. J Mol Biol. 2007;366:1603\u201314. https:\/\/doi.org\/10.1016\/J.JMB.2006.12.027.","journal-title":"J Mol Biol"},{"key":"7153_CR53","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/j.cmet.2024.05.014","volume":"36","author":"Z Wu","year":"2024","unstructured":"Wu Z, Bezwada D, Cai F, Harris RC, Ko B, Sondhi V, et al. Electron transport chain inhibition increases cellular dependence on purine transport and salvage. Cell Metab. 2024;36:1504-1520.e9. https:\/\/doi.org\/10.1016\/j.cmet.2024.05.014.","journal-title":"Cell Metab"},{"issue":"2","key":"7153_CR54","doi-asserted-by":"publisher","first-page":"241","DOI":"10.24272\/J.ISSN.2095-8137.2021.420","volume":"43","author":"R Tian","year":"2022","unstructured":"Tian R, Yang C, Chai S-M, Guo H, Seim I, Yang G. Evolutionary impacts of purine metabolism genes on mammalian oxidative stress adaptation. Zool Res. 2022;43(2):241\u201354. https:\/\/doi.org\/10.24272\/J.ISSN.2095-8137.2021.420.","journal-title":"Zool Res"},{"key":"7153_CR55","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.2741\/4555","volume":"22","author":"AM Whitaker","year":"2017","unstructured":"Whitaker AM, Schaich MA, Smith MS, Flynn TS, Freudenthal BD. Base excision repair of oxidative DNA damage: from mechanism to disease. Front Biosci (Landmark Ed). 2017;22:1493\u2013522. https:\/\/doi.org\/10.2741\/4555.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"7153_CR56","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1038\/S12276-021-00700-0","volume":"53","author":"Y Huang","year":"2021","unstructured":"Huang Y, Li Z, Lin E, He P, Ru G. Oxidative damage-induced hyperactive ribosome biogenesis participates in tumorigenesis of offspring by cross-interacting with the Wnt and TGF-\u03b21 pathways in IVF embryos. Exp Mol Med. 2021;53:1792. https:\/\/doi.org\/10.1038\/S12276-021-00700-0.","journal-title":"Exp Mol Med"},{"key":"7153_CR57","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/NATURE12922","volume":"505","author":"A Obri","year":"2014","unstructured":"Obri A, Ouararhni K, Papin C, Diebold ML, Padmanabhan K, Marek M, et al. ANP32E is a histone chaperone that removes H2A.Z from chromatin. Nature. 2014;505:648\u201353. https:\/\/doi.org\/10.1038\/NATURE12922.","journal-title":"Nature"},{"key":"7153_CR58","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/CEI.12658","volume":"182","author":"S Peng","year":"2015","unstructured":"Peng S, Wang K, Gu Y, Chen Y, Nan X, Xing J, et al. TRAF3IP3, a novel autophagy up-regulated gene, is involved in marginal zone B lymphocyte development and survival. Clin Exp Immunol. 2015;182:57\u201368. https:\/\/doi.org\/10.1111\/CEI.12658.","journal-title":"Clin Exp Immunol"},{"key":"7153_CR59","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1084\/JEM.20150110","volume":"212","author":"Q Zou","year":"2015","unstructured":"Zou Q, Jin J, Xiao Y, Hu H, Zhou X, Jie Z, et al. T cell development involves TRAF3IP3-mediated ERK signaling in the Golgi. J Exp Med. 2015;212:1323\u201336. https:\/\/doi.org\/10.1084\/JEM.20150110.","journal-title":"J Exp Med"},{"key":"7153_CR60","doi-asserted-by":"publisher","first-page":"4876","DOI":"10.4049\/JIMMUNOL.157.11.4876","volume":"157","author":"JR Ostberg","year":"1996","unstructured":"Ostberg JR, Dragone LL, Driskell T, Moynihan JA, Phipps R, Barth RK, et al. Disregulated expression of CD43 (leukosialin, sialophorin) in the B cell lineage leads to immunodeficiency. J Immunol. 1996;157:4876\u201384. https:\/\/doi.org\/10.4049\/JIMMUNOL.157.11.4876.","journal-title":"J Immunol"},{"key":"7153_CR61","doi-asserted-by":"publisher","first-page":"6643","DOI":"10.1002\/JCP.30308","volume":"236","author":"D Vega-Mendoza","year":"2021","unstructured":"Vega-Mendoza D, Ca\u00f1as-Linares A, Flores-Alcantar A, Espinosa-Neira R, Melchy-Perez E, Vera-Estrella R, et al. CD43 (sialophorin) is involved in the induction of extracellular matrix remodeling and angiogenesis by lung cancer cells. J Cell Physiol. 2021;236:6643\u201356. https:\/\/doi.org\/10.1002\/JCP.30308.","journal-title":"J Cell Physiol"},{"key":"7153_CR62","doi-asserted-by":"publisher","first-page":"58","DOI":"10.4049\/JIMMUNOL.1900539","volume":"204","author":"ZJ Greenberg","year":"2020","unstructured":"Greenberg ZJ, Monlish DA, Bartnett RL, Yang Y, Shen G, Li W, et al. The tetraspanin CD53 regulates early B cell development by promoting IL-7R signaling. J Immunol. 2020;204:58\u201367. https:\/\/doi.org\/10.4049\/JIMMUNOL.1900539.","journal-title":"J Immunol"},{"key":"7153_CR63","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1194\/JLR.M800453-JLR200","volume":"50","author":"T Uyama","year":"2009","unstructured":"Uyama T, Morishita J, Jin XH, Okamoto Y, Tsuboi K, Ueda N. The tumor suppressor gene H-Rev107 functions as a novel Ca2+-independent cytosolic phospholipase A1\/2 of the thiol hydrolase type. J Lipid Res. 2009;50:685\u201393. https:\/\/doi.org\/10.1194\/JLR.M800453-JLR200.","journal-title":"J Lipid Res"},{"key":"7153_CR64","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/J.BBALIP.2009.07.001","volume":"1791","author":"T Uyama","year":"2009","unstructured":"Uyama T, Jin XH, Tsuboi K, Tonai T, Ueda N. Characterization of the human tumor suppressors TIG3 and HRASLS2 as phospholipid-metabolizing enzymes. Biochim Biophys Acta. 2009;1791:1114\u201324. https:\/\/doi.org\/10.1016\/J.BBALIP.2009.07.001.","journal-title":"Biochim Biophys Acta"},{"key":"7153_CR65","doi-asserted-by":"publisher","first-page":"23790","DOI":"10.1074\/JBC.M112.361550","volume":"287","author":"M Golczak","year":"2012","unstructured":"Golczak M, Kiser PD, Sears AE, Lodowski DT, Blaner WS, Palczewski K. Structural basis for the acyltransferase activity of lecithin:retinol acyltransferase-like proteins. J Biol Chem. 2012;287:23790\u2013807. https:\/\/doi.org\/10.1074\/JBC.M112.361550.","journal-title":"J Biol Chem"},{"key":"7153_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/S12929-015-0210-7","author":"EB Mardian","year":"2015","unstructured":"Mardian EB, Bradley RM, Duncan RE. The HRASLS (PLA\/AT) subfamily of enzymes. J Biomed Sci. 2015;22:99. https:\/\/doi.org\/10.1186\/S12929-015-0210-7","journal-title":"J Biomed Sci"},{"key":"7153_CR67","doi-asserted-by":"publisher","first-page":"31905","DOI":"10.1074\/JBC.M112.368712","volume":"287","author":"T Uyama","year":"2012","unstructured":"Uyama T, Ikematsu N, Inoue M, Shinohara N, Jin XH, Tsuboi K, et al. Generation of N-acylphosphatidylethanolamine by members of the phospholipase A\/acyltransferase (PLA\/AT) family. J Biol Chem. 2012;287:31905\u201319. https:\/\/doi.org\/10.1074\/JBC.M112.368712.","journal-title":"J Biol Chem"},{"key":"7153_CR68","doi-asserted-by":"publisher","first-page":"5296","DOI":"10.1158\/0008-5472.CAN-21-0757\/674277\/AM\/DIETARY-FATS-HIGH-IN-LINOLEIC-ACIDS-IMPAIR-ANTI","volume":"81","author":"R Jin","year":"2021","unstructured":"Jin R, Hao J, Yi Y, Yin D, Hua Y, Li X, et al. Dietary fats high in linoleic acids impair anti-tumor T cell responses by inducing E-FABP-mediated mitochondrial dysfunction. Cancer Res. 2021;81:5296\u2013310. https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-0757\/674277\/AM\/DIETARY-FATS-HIGH-IN-LINOLEIC-ACIDS-IMPAIR-ANTI.","journal-title":"Cancer Res"},{"issue":"11","key":"7153_CR69","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/sj.cdd.4400938","volume":"8","author":"JYJ Wang","year":"2001","unstructured":"Wang JYJ. DNA damage and apoptosis. Cell Death Differ. 2001;8(11):1047\u20138. https:\/\/doi.org\/10.1038\/sj.cdd.4400938.","journal-title":"Cell Death Differ"},{"key":"7153_CR70","doi-asserted-by":"publisher","unstructured":"Ko S, Woo TG, Lee SH, Ha NC, Park BJ. Arachidonic acid induces apoptosis under serum-free conditions by blocking PAK1-mediated PUMA suppression 2024;9(1):2053. https:\/\/doi.org\/10.25107\/2474-1663-v9-id2053","DOI":"10.25107\/2474-1663-v9-id2053"},{"key":"7153_CR71","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9965737","volume":"2021","author":"S Liu","year":"2021","unstructured":"Liu S, Wang Q, Li Z, Ma L, Li T, Li Y, et al. TRPV1 channel activated by the PGE2\/EP4 pathway mediates spinal hypersensitivity in a mouse model of vertebral endplate degeneration. Oxid Med Cell Longev. 2021;2021:9965737. https:\/\/doi.org\/10.1155\/2021\/9965737.","journal-title":"Oxid Med Cell Longev"},{"key":"7153_CR72","doi-asserted-by":"publisher","first-page":"11021","DOI":"10.1074\/JBC.M008392200","volume":"276","author":"Z Olah","year":"2001","unstructured":"Olah Z, Szabo T, Karai L, Hough C, Fields RD, Caudle RM, et al. Ligand-induced dynamic membrane changes and cell deletion conferred by vanilloid receptor 1. J Biol Chem. 2001;276:11021\u201330. https:\/\/doi.org\/10.1074\/JBC.M008392200.","journal-title":"J Biol Chem"},{"key":"7153_CR73","doi-asserted-by":"publisher","unstructured":"Munaron L, Tomatis C, Fiorio Pla A, Author C. The secret marriage between calcium and tumor angiogenesis 2008;7(4):335\u20139. https:\/\/doi.org\/10.1177\/153303460800700408","DOI":"10.1177\/153303460800700408"},{"key":"7153_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/J.CECA.2019.102132","volume":"85","author":"A Mangla","year":"2020","unstructured":"Mangla A, Guerra MT, Nathanson MH. Type 3 inositol 1,4,5-trisphosphate receptor: a calcium channel for all seasons. Cell Calcium. 2020;85:102132. https:\/\/doi.org\/10.1016\/J.CECA.2019.102132.","journal-title":"Cell Calcium"},{"issue":"5","key":"7153_CR75","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrc2842","volume":"10","author":"TD Bunney","year":"2010","unstructured":"Bunney TD, Katan M. Phosphoinositide signalling in cancer: beyond PI3K and PTEN. Nat Rev Cancer. 2010;10(5):342\u201352. https:\/\/doi.org\/10.1038\/nrc2842.","journal-title":"Nat Rev Cancer"},{"key":"7153_CR76","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1159\/000471912","volume":"41","author":"AF Silva-Filho","year":"2017","unstructured":"Silva-Filho AF, Sena WLB, Lima LRA, Carvalho LVN, Pereira MC, Santos LGS, et al. Glycobiology modifications in intratumoral hypoxia: the breathless side of glycans interaction. Cell Physiol Biochem. 2017;41:1801\u201329. https:\/\/doi.org\/10.1159\/000471912.","journal-title":"Cell Physiol Biochem"},{"key":"7153_CR77","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/J.APSB.2023.10.014","volume":"14","author":"Y Lin","year":"2023","unstructured":"Lin Y, Lubman DM. The role of N-glycosylation in cancer. Acta Pharm Sin B. 2023;14:1098. https:\/\/doi.org\/10.1016\/J.APSB.2023.10.014.","journal-title":"Acta Pharm Sin B"},{"issue":"8","key":"7153_CR78","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1038\/s41416-020-1007-3","volume":"123","author":"Y Wang","year":"2020","unstructured":"Wang Y, Li Q, Niu L, Xu L, Guo Y, Wang L, et al. Suppression of G6PD induces the expression and bisecting GlcNAc-branched N-glycosylation of E-cadherin to block epithelial-mesenchymal transition and lymphatic metastasis. Br J Cancer. 2020;123(8):1315\u201325. https:\/\/doi.org\/10.1038\/s41416-020-1007-3.","journal-title":"Br J Cancer"},{"key":"7153_CR79","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1111\/J.1742-4658.2008.06346.X","volume":"275","author":"Y Zhao","year":"2008","unstructured":"Zhao Y, Sato Y, Isaji T, Fukuda T, Matsumoto A, Miyoshi E, et al. Branched N-glycans regulate the biological functions of integrins and cadherins. FEBS J. 2008;275:1939\u201348. https:\/\/doi.org\/10.1111\/J.1742-4658.2008.06346.X.","journal-title":"FEBS J"},{"issue":"6","key":"7153_CR80","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1203\/00006450-199706000-00009","volume":"41","author":"N Cheng","year":"1997","unstructured":"Cheng N, Cai W, Jiang M, Wu S. Effect of hypoxia on blood glucose, hormones, and insulin receptor functions in newborn calves. Pediatr Res. 1997;41(6):852\u20136. https:\/\/doi.org\/10.1203\/00006450-199706000-00009.","journal-title":"Pediatr Res"},{"key":"7153_CR81","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1385\/ENDO:11:1:37\/METRICS","volume":"11","author":"H Raff","year":"1999","unstructured":"Raff H, Bruder ED, Jankowski BM. The effect of hypoxia on plasma leptin and insulin in newborn and juvenile rats. Endocrine. 1999;11:37\u20139. https:\/\/doi.org\/10.1385\/ENDO:11:1:37\/METRICS.","journal-title":"Endocrine"},{"issue":"11","key":"7153_CR82","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1164\/RCCM.200308-1200OC","volume":"169","author":"KM Oltmanns","year":"2012","unstructured":"Oltmanns KM, Gehring H, Rudolf S, Schultes B, Rook S, Schweiger U, et al. Hypoxia causes glucose intolerance in humans. Am J Respir Crit Care Med. 2012;169(11):1231\u20137. https:\/\/doi.org\/10.1164\/RCCM.200308-1200OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"7153_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS21072428","author":"F Dengler","year":"2020","unstructured":"Dengler F. Activation of AMPK under hypoxia: many roads leading to Rome. Int J Mol Sci. 2020;21(7):2428. https:\/\/doi.org\/10.3390\/IJMS21072428","journal-title":"Int J Mol Sci"},{"key":"7153_CR84","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1113\/JPHYSIOL.2003.048173","volume":"552","author":"VY Polotsky","year":"2003","unstructured":"Polotsky VY, Li J, Punjabi NM, Rubin AE, Smith PL, Schwartz AR, et al. Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol. 2003;552:253\u201364. https:\/\/doi.org\/10.1113\/JPHYSIOL.2003.048173.","journal-title":"J Physiol"},{"key":"7153_CR85","doi-asserted-by":"publisher","DOI":"10.1152\/AJPENDO.00532.2003","author":"I Leclerc","year":"2004","unstructured":"Leclerc I, Woltersdorf WW, Da Silva Xavier G, Rowe RL, Cross SE, Korbutt GS, et al. Metformin, but not leptin, regulates AMP-activated protein kinase in pancreatic islets: impact on glucose-stimulated insulin secretion. Am J Physiol Endocrinol Metab. 2004;286(6):E1023\u2013E1031. https:\/\/doi.org\/10.1152\/AJPENDO.00532.2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"7153_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/FENDO.2022.869414\/BIBTEX","volume":"13","author":"T Murakami","year":"2022","unstructured":"Murakami T, Inagaki N, Kondoh H. Cellular senescence in diabetes mellitus: distinct senotherapeutic strategies for adipose tissue and pancreatic \u03b2 Cells. Front Endocrinol (Lausanne). 2022;13:869414. https:\/\/doi.org\/10.3389\/FENDO.2022.869414\/BIBTEX.","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07153-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07153-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07153-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T14:36:03Z","timestamp":1762958163000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-07153-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7153"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07153-3","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"4 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent to the publication of this work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they do not have any competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1268"}}